AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,416,000 | -36.6% | 209,196 | -47.6% | 0.02% | +22.2% |
| Q3 2021 | $3,808,000 | +103.5% | 398,930 | +105.5% | 0.02% | 0.0% |
| Q2 2021 | $1,871,000 | +3.5% | 194,165 | +6.1% | 0.02% | 0.0% |
| Q1 2021 | $1,807,000 | -57.8% | 182,917 | -1.4% | 0.02% | -62.5% |
| Q4 2020 | $4,284,000 | +60.5% | 185,533 | -1.8% | 0.05% | +33.3% |
| Q3 2020 | $2,669,000 | +241.7% | 188,986 | +265.2% | 0.04% | +176.9% |
| Q2 2020 | $781,000 | +68.7% | 51,753 | +3.2% | 0.01% | +44.4% |
| Q1 2020 | $463,000 | -14.7% | 50,170 | -10.1% | 0.01% | +12.5% |
| Q4 2019 | $543,000 | +13.1% | 55,777 | -6.9% | 0.01% | +14.3% |
| Q3 2019 | $480,000 | -35.5% | 59,910 | +0.4% | 0.01% | -36.4% |
| Q2 2019 | $744,000 | -7.9% | 59,661 | +0.4% | 0.01% | -15.4% |
| Q1 2019 | $808,000 | +45.8% | 59,414 | +2.7% | 0.01% | +30.0% |
| Q4 2018 | $554,000 | +9.1% | 57,826 | +37.6% | 0.01% | +42.9% |
| Q3 2018 | $508,000 | -22.7% | 42,025 | -0.1% | 0.01% | -30.0% |
| Q2 2018 | $657,000 | – | 42,059 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |